4.6 Article

Structural insights into the interactions between lloviu virus VP30 and nucleoprotein

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2022.05.059

Keywords

Lloviu virus; VP30; NP; Crystal structure; Interaction

Funding

  1. National key R&D Program of China [2018YFD1000501]
  2. National Natural Science Foundation of China [32070267, 31622007, 31670237]
  3. Shandong Provincial Natural Science Foundation, China [ZR2019ZD48, ZR2020QC057]
  4. Taishan Scholars Project [tsqn201812079]
  5. Higher Educational Science and Technology Program of Jinan City [2020GXRC058]

Ask authors/readers for more resources

The interactions between the VP30 C-terminal domain (CTD) of Lloviu virus (LLOV) and its nucleoprotein (NP) fragment were confirmed, and the crystal structure of the chimeric dimeric LLOV NP-VP30 CTD was determined. This provides a preliminary model for investigating interactions between LLOV VP30 and NP and suggests a potential target for anti-filovirus drug development.
The family Filoviridae comprises many notorious viruses, such as Ebola virus (EBOV) and Marburg virus (MARV), that can infect humans and nonhuman primates. Lloviu virus (LLOV), a less well studied filovirus, is considered a potential pathogen for humans. The VP30 C-terminal domain (CTD) of these filoviruses exhibits nucleoprotein (NP) binding and plays an essential role in viral transcription, replication and assembly. In this study, we confirmed the interactions between LLOV VP30 CTD and its NP fragment, and also determined the crystal structure of the chimeric dimeric LLOV NP-VP30 CTD at 2.50 A resolution. The structure is highly conserved across the family Filoviridae. While in the dimer structure, only one VP30 CTD binds the NP fragment, which indicates that the interaction between LLOV VP30 CTD and NP is not strong. Our work provides a preliminary model to investigate the interactions between LLOV VP30 and NP and suggests a potential target for anti-filovirus drug development. (C) 2022 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available